Log in to save to my catalogue
Log in to save to my catalogue

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

| Ask | Become a Library member

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2433290614

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

About this item

Publication information

Publisher

United States: Massachusetts Medical Society

Subjects

Subjects and topics

More information

Scope and Contents

Contents

In more than 400 older patients with AML who could not receive myeloablative therapy, the incidence of composite complete remission was higher (66.4% vs. 28.3) and the median overall survival was longer (14.7 vs. 9.6 months) among patients who received azacitidine plus venetoclax (a B-cell lymphoma 2 antagonist) than among those who received azacit...

Alternative Titles

Full title

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2433290614

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2433290614

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2012971

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections